The Florance and Cope Professorial Department of Rheumatology brings together scientific researchers and medical clinicians with a common interest in improving outcomes for those with musculoskeletal conditions.
We are currently conducting research into the causes, impact and treatment of a wide range of disorders in addition to raising awareness of the burden of musculoskeletal conditions.
Our aim is to advance the understanding of the musculoskeletal system. The main focus of our research includes clinical and translational research in inflammatory arthritis, osteoarthritis, low back pain and other rheumatic diseases. While these areas are a focus, our clinicians and researchers are also investigating osteonecrosis, systemic lupus erythematosus, rheumatoid arthritis and psoriatic arthritis.
Our researchers are members of national and international advisory committees that raise awareness and promote care and research on musculoskeletal conditions. We are the Home Office for the Global Alliance for Musculoskeletal Conditions.
We are the national lead site for A3BC – the Australian Arthritis and Autoimmune diseases Biobank Collaborative, and we encourage the involvement of patient research partners in all our projects.
We aim to make precision medicine – giving the targeted right treatment to the right patient at the right time – a reality. Through all of our work we are building a national resource to work towards a cure for musculoskeletal conditions

Lead

People

Network

Projects
Associate Professor Sean O’Neill
Clinical Academic Rheumatologist
The University of Sydney
Head of Department
Department of Rheumatology
Royal North Shore Hospital
Professor David Hunter
Florance and Cope Chair of Rheumatology
Staff Specialist Rheumatologist, Royal North Shore Hospital
Professor of Medicine, University of Sydney
Sydney Musculoskeletal Research Centre
Professor Lyn March AM
Project Lead and Coordinating Principal Investigator
Australian Arthritis and Autoimmune Biobank Collaborative (A3BC), The University of Sydney
Liggins Professor of Rheumatology & Musculoskeletal Epidemiology
Head of Department, Department of Rheumatology, Royal North Shore Hospital
Dr Marita Cross
Postdoctoral Research Associate
The University of Sydney
Dr Jie Yi
Clinical Trial Coordinator
The University of Sydney
Dr Fiona Howard
National Juvenile Arthritis Project Officer
The University Of Sydney
Tom Lynch
Senior Project Officer, A3BC
The University of Sydney
Dr Leticia Deveza
Research Affiliate
Faculty of Medicine and Health, University of Sydney
Rheumatologists, Royal North shore Hospital
Sydney Musculoskeletal Research Centre
Associate Professor Leslie Schrieber
Medicine, Northern Clinical School
Dr Premarani Sinnathurai
Clinical Lecturer. Northern Clinical School
Dr Shirley Yu
Research Fellow
Faculty of Medicine and Health, University of Sydney
Rheumatologists, Royal North Shore Hospital
Sydney Musculoskeletal Research Centre
Dr Ross Penglase
Locum Staff Specialist Rheumatologist
Department of Rheumatology, Royal North Shore Hospital
Dr Mariya Kitson
Locum Staff Specialist Rheumatologist
Department of Rheumatology, Royal North Shore Hospital
Dr Natasha Ung
Locum Staff Specialist Rheumatologist
Department of Rheumatology, Royal North Shore Hospital
Helen Martin
Rheumatology Clinical Nurse
Melanie Ross
Rheumatology Clinical Nurse
The aim of the rheumatology department is to advance the understanding of the musculoskeletal system. The main focus of our research includes clinical and translational research in osteoarthritis, low back pain and other rheumatic diseases.
Using a combination of clinical, data science and laboratory research methods this PhD project aims to investigate predictors and predictive models of inflammatory arthritis using samples and data from a national biobank-registry project, the Australian Arthritis and Autoimmune Biobank Collaborative (A3BC) and Australian Rheumatology Association Database (ARAD). The primary hypothesis is that inflammatory arthritis outcomes can be predicted and optimised by integrating diverse predictor variables across clinical, biological, self-reported, biometric and administrative health data domains to inform critical management decisions at key timepoints in the disease course. The ultimate goals of this field are improved population medicine policy and practice in the form of new, improved and more targeted treatments, better preventative and management strategies and, ideally, progress towards complete cures for these diseases. The expected research contribution is a thesis containing a series of publications around the common themes of personalised / precision medicine in inflammatory arthritis, predictive modelling, and the role of biobank-registries in facilitating this type of research.
https://kollinginstitute.org.au/osteoarthritis-research
https://kollinginstitute.org.au/back-pain-research
https://kollinginstitute.org.au/sutton-arthritis-research-laboratory
- The causes, impact and treatment of a wide range of musculoskeletal/ rheumatological disorders.
- Key research areas: inflammatory arthritis (rheumatoid arthritis, psoriatic arthritis, etc), systemic lupus erythematosus, osteoarthritis, osteoporosis, low back pain.
- Development and implementation of evidence-based clinical guidelines.
- Global Burden of Diseases Study (Musculoskeletal disorders).
- The A3BC Biobank (https://a3bc.org.au/)
- ARAD (https://www.arad.org.au/Public/Home.aspx)
- Baricitinib therapy for rheumatoid arthritis: an observational study.






